Myriad Genetics Inc.

NASDAQ: MYGN · Real-Time Price · USD
5.71
-0.18 (-3.06%)
At close: Aug 15, 2025, 3:59 PM
5.75
0.61%
After-hours: Aug 15, 2025, 07:15 PM EDT

Myriad Genetics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
213.1M 195.9M 210.6M 213.3M 211.5M 202.2M 196.6M 191.9M 183.5M 181.2M 177.8M 156.4M 179.3M 164.9M 160.8M 167.3M 189.4M 173.1M
Cost of Revenue
61.3M 61.7M 59.7M 63.5M 64.4M 64.6M 61.6M 57.6M 57.8M 59.2M 53.9M 50.4M 49.7M 48M 45.8M 47.8M 53.7M 50.3M
Gross Profit
151.8M 134.2M 150.9M 149.8M 147.1M 137.6M 135M 134.3M 125.7M 122M 123.9M 106M 129.6M 116.9M 115M 119.5M 135.7M 122.8M
Operating Income
-329.2M -29M -39M -20M -36.5M -27.9M -31.4M -60.1M -113.7M -52.2M -46M -45M -17.8M -14.9M -43.1M -79.9M -20.8M -46.7M
Interest Income
200K 300K 300K 400K 400K 600K 700K 600K 500K 700K 1M 1.1M 400K 100K 100K 200K 200K 200K
Pretax Income
-330.6M -29.4M -39.1M -21.2M -37.2M -25.9M -32.3M -61.2M -116.1M -52.6M -52.1M -44.2M -17.9M -26.4M -43.5M 39.8M -3.8M -49.6M
Net Income
-330.5M -100K -42.5M -22.1M -36.7M -26M -31.2M -61.3M -116.1M -54.7M -42.3M -35.1M -14.1M -20.5M -7.6M 24.6M -4.7M -39.5M
Selling & General & Admin
138.7M 135.7M 136M 139.1M 144.9M 140.6M 32.6M 170.4M 218.2M 151.7M 146.5M 130.5M 127.1M 110.6M 141.5M 180.2M 134.8M 145.5M
Research & Development
25.6M 27.5M 32.2M 28.5M 27.1M 24.9M 21M 24M 21.2M 22.5M 23.4M 20.5M 20.3M 21.2M 16.6M 18.8M 19.5M 23.1M
Other Expenses
316.7M n/a 21.7M 2.2M 11.6M n/a 112.8M -700K n/a -600K n/a 500K 100K n/a -100K n/a n/a -100K
Operating Expenses
481M 163.2M 189.9M 169.8M 183.6M 165.5M 166.4M 194.4M 239.4M 174.2M 169.9M 151M 147.4M 131.8M 158.1M 199M 154.3M 168.6M
Interest Expense
1.5M 800K 700K 800K 800K 500K 900K 1M 500K 500K 900K 800K 600K 900K 500K 1.1M 2M 3M
Selling & Marketing Expenses
71.9M 69.2M 284.1M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
542.3M 224.9M 249.6M 233.3M 248M 230.1M 228M 252M 297.2M 233.4M 223.8M 201.4M 197.1M 179.8M 203.9M 246.8M 208M 218.9M
Income Tax Expense
-100K -29.3M 3.4M 900K -500K 100K -1.1M 100K -1.9M 2.1M -9.8M -9.1M -3.8M -5.9M -35.9M 15.2M 900K -10.1M
Shares Outstanding (Basic)
92.5M 91.4M 91.1M 90.9M 90.6M 89.9M 86.1M 81.73M 81.7M 81.3M 81.5M 80.7M 78.33M 78.85M 76.14M 78.8M 77.2M 75.96M
Shares Outstanding (Diluted)
92.5M 91.4M 91.1M 90.9M 90.6M 89.9M 86.1M 81.9M 81.7M 81.3M 81.5M 80.7M 80.4M 80.1M 79.9M 81.5M 77.2M 76M
EPS (Basic)
-3.57 -0.00 -0.47 -0.24 -0.41 -0.29 -0.36 -0.75 -1.42 -0.67 -0.52 -0.43 -0.18 -0.26 -0.1 0.31 -0.06 -0.52
EPS (Diluted)
-3.57 -0.00 -0.47 -0.24 -0.41 -0.29 -0.36 -0.75 -1.42 -0.67 -0.52 -0.43 -0.18 -0.26 -0.1 0.30 -0.06 -0.52
EBITDA
-315M -14.2M -23.6M -2.2M -21.2M -9.7M -16.3M -46.1M -102.3M -32.7M -31.3M -30.3M -4.4M -1.8M -29.7M 55.5M 17.3M -27.3M
EBIT
-329.1M -28.6M -38.4M -20.4M -36.4M -25.4M -31.4M -60.1M n/a -52.2M -46M -45M -17.8M -14.9M -43.1M n/a n/a n/a
Depreciation & Amortization
14.1M 14.4M 14.8M 15.6M 15.1M 15.7M 15.1M 14.1M 13.3M 19.5M 14.7M 14.7M 13.4M 13.1M 13.3M 14.2M 16.9M 18.4M